Psychiatry and Neurology, Neurology · Glen Burnie, MD
NPI
1316966179
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1412 Crain Hwy N Ste 6a
Glen Burnie, MD, 21061
Phone (410) 761-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
82,324 services
Medicare patients, 2024
1,076
Average age 71
Drug cost, 2024
$7.8M
6,154 prescriptions
Company payments, 2025
$234K
From 47 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sangjin Oh was code J3032 (injection, eptinezumab-jjmr, 1 mg), 18,900 times for 20 patients. In total Sangjin Oh billed 82,324 services in 49 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 18,900 | 20 | $14.36 | $271K |
| J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 12,590 | 11 | $52.60 | $662K |
| 99214 Office E&M - Established | Office | 1,208 | 785 | $82.60 | $100K |
| 96366 Intravenous Infusion, Hydration | Office | 309 | 13 | $15.37 | $4,750 |
| 96365 Intravenous Infusion, Hydration | Office | 268 | 39 | $47.90 | $13K |
| 99205 Office E&M - New | Office | 208 | 208 | $154.89 | $32K |
| 95886 Electrical Nerve Conductivity | Office | 135 | 129 | $71.34 | $9,630 |
| 99203 Office E&M - New | Office | 107 | 106 | $77.58 | $8,301 |
| 99442 Telephone Services | Office | 81 | 67 | $65.78 | $5,328 |
| 95911 Electrical Nerve Conductivity | Office | 55 | 55 | $159.12 | $8,751 |
| 95912 Electrical Nerve Conductivity | Office | 46 | 46 | $183.47 | $8,440 |
| 96413 Chemotherapy Administration | Office | 33 | 16 | $95.96 | $3,167 |
| 95806 Sleep Study | Office | 31 | 23 | $66.68 | $2,067 |
| 95819 Neurologic | Office | 31 | 31 | $343.89 | $11K |
| 96375 Injection Administration | Office | 29 | 11 | $11.64 | $337 |
By year: 2022 $2.0M for 42,678 services; 2023 $2.5M for 54,121 services; 2024 $2.8M for 82,324 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sangjin Oh prescribed most often to Medicare patients was Gabapentin, with 430 prescriptions and refills. In total Sangjin Oh wrote 6,154 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 430 | 1,025 | 160 | $10K |
| Memantine Hcl Generic | 289 | 692 | 83 | $14K |
| Kesimpta Pen Ofatumumab | 277 | 297 | 33 | $2.8M |
| Donepezil Hcl Generic | 271 | 665 | 83 | $3,547 |
| Levetiracetam Generic | 218 | 525 | 59 | $10K |
| Quetiapine Fumarate Generic | 211 | 535 | 71 | $3,446 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 208 | 564 | 66 | $5,662 |
| Duloxetine Hcl Generic | 189 | 451 | 61 | $7,562 |
| Pregabalin Generic | 162 | 367 | 56 | $7,644 |
| Topiramate Generic | 147 | 377 | 58 | $2,937 |
| Amitriptyline Hcl Generic | 145 | 377 | 53 | $2,728 |
| Divalproex Sodium Er Divalproex Sodium | 143 | 332 | 46 | $8,713 |
| Trazodone Hcl Generic | 127 | 357 | 49 | $1,822 |
| Primidone Generic | 126 | 312 | 43 | $5,461 |
| Baclofen Generic | 121 | 327 | 47 | $4,317 |
Brand drugs: 1,158 claims; generic drugs: 4,972 claims; opioid claims: 97.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sangjin Oh $234K ($234K in general payments such as food, travel and fees) from 47 companies. The largest payer was EMD Serono, Inc. with $82K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 81 | $82K |
| TG Therapeutics, Inc. TGTX | 52 | $54K |
| Vanda Pharmaceuticals Inc. VNDA | 62 | $29K |
| Biogen, Inc. BIIB | 50 | $21K |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $13K |
| Lilly USA, LLC LLY | 17 | $12K |
| Abbvie Inc. ABBV | 50 | $8,855 |
| Genentech USA, Inc. ROG.SW | 19 | $6,969 |
| Pfizer Inc. PFE | 14 | $1,175 |
| Celgene Corporation BMY | 29 | $664 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.